SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-065159
Filing Date
2023-11-20
Accepted
2023-11-20 16:51:15
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-20230930.htm   iXBRL 10-Q 2018873
2 EX-3.3 acer-ex3_3.htm EX-3.3 27658
3 EX-31.1 acer-ex31_1.htm EX-31.1 14841
4 EX-31.2 acer-ex31_2.htm EX-31.2 14744
5 EX-32.1 acer-ex32_1.htm EX-32.1 9218
6 EX-32.2 acer-ex32_2.htm EX-32.2 9200
7 GRAPHIC img229400419_0.jpg GRAPHIC 17508
  Complete submission text file 0000950170-23-065159.txt   10928185

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acer-20230930_lab.xml EX-101.LAB 716177
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acer-20230930_pre.xml EX-101.PRE 512885
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acer-20230930_def.xml EX-101.DEF 364506
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acer-20230930.xsd EX-101.SCH 99534
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acer-20230930_cal.xml EX-101.CAL 50988
67 EXTRACTED XBRL INSTANCE DOCUMENT acer-20230930_htm.xml XML 2041505
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 231423389
SIC: 2834 Pharmaceutical Preparations